A Devon pharmaceutical company is working on cannabinoid therapies to treat genetic conditions. In the meantime, Zynerba Pharmaceuticals is planning a reverse stock split by…

Zynerba Pharmaceuticals, a clinical-stage pharmaceutical company based in Devon, is testing a CBD gel to help treat autism, writes Queen Muse for Philadelphia magazine…

Devon-based Zynerba Pharmaceuticals saw its shares surge after it received a U.S. patent for its cannabidiol (CBD) gel to treat Autism Spectrum Disorders…

Devon-based Zynerba Pharmaceuticals has received “Fast Track” status from the FDA for its synthetic cannabidiol drug intended to treat symptoms associated with Fragile X…